These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17593065)

  • 1. Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'.
    Pace F; Tonini M; Pallotta S; Molteni P; Porro GB
    Aliment Pharmacol Ther; 2007 Jul; 26(2):195-204. PubMed ID: 17593065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
    Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    Lee TJ; Fennerty MB; Howden CW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1241-51. PubMed ID: 15606386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
    Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M
    J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis.
    Khan Z; Alastal Y; Khan MA; Khan MS; Khalil B; Shrestha S; Kamal F; Nawras A; Howden CW
    Gastroenterol Res Pract; 2018; 2018():6417526. PubMed ID: 30158966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: management of mild and severe gastro-oesophageal reflux disease.
    Tytgat GN
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():52-6. PubMed ID: 12786613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease.
    Bardhan KD
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S40-8. PubMed ID: 12644030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gastroesophageal reflux disease in adults: an individualized approach.
    Galmiche JP; Stephenson K
    Dig Dis; 2004; 22(2):148-60. PubMed ID: 15383756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.
    Donnellan C; Preston C; Moayyedi P; Sharma N
    Cochrane Database Syst Rev; 2010 Feb; (2):CD003245. PubMed ID: 20166065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis.
    Kang SJ; Jung HK; Tae CH; Kim SY; Lee KJ
    J Neurogastroenterol Motil; 2022 Jan; 28(1):5-14. PubMed ID: 34980685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.
    Donnellan C; Sharma N; Preston C; Moayyedi P
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003245. PubMed ID: 15846653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
    Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
    Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
    Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-demand PPI therapy in GERD.
    Pace F; Porro GB
    Curr Treat Options Gastroenterol; 2008 Feb; 11(1):35-42. PubMed ID: 21063862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.